Seres Therapeutics Inc (NASDAQ: MCRB) is -47.14% lower on its value in year-to-date trading and has touched a low of $0.54 and a high of $6.26 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MCRB stock was last observed hovering at around $0.61 in the last trading session, with the day’s gains setting it 0.13%.
Currently trading at $0.74, the stock is -21.63% and -13.82% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 15.79 million and changing 20.54% at the moment leaves the stock -45.67% off its SMA200. MCRB registered -86.78% loss for a year compared to 6-month loss of -32.72%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -28.15% gain in the last 1 month and extending the period to 3 months gives it a -13.94%, and is -31.47% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 28.01% over the week and 13.89% over the month.
Seres Therapeutics Inc (MCRB) has around 233 employees, a market worth around $112.09M and $126.85M in sales. Profit margin for the company is -65.18%. Distance from 52-week low is 37.06% and -88.18% from its 52-week high. The company has generated returns on investments over the last 12 months (-56.78%).
The EPS is expected to shrink by -6.59% this year.
Seres Therapeutics Inc (MCRB) Top Institutional Holders
The shares outstanding are 135.04M, and float is at 119.77M with Short Float at 18.98%.
Seres Therapeutics Inc (MCRB) Insider Activity
The most recent transaction is an insider sale by Shaff Eric D.,the company’sCEO and President. SEC filings show that Shaff Eric D. sold 2,435 shares of the company’s common stock on May 15 ’24 at a price of $0.94 per share for a total of $2289.0. Following the sale, the insider now owns 0.14 million shares.
Seres Therapeutics Inc disclosed in a document filed with the SEC on May 15 ’24 that Ege David S.sold a total of 1,090 shares of the company’s common stock. The trade occurred on May 15 ’24 and was made at $0.94 per share for $1025.0. Following the transaction, the insider now directly holds 75734.0 shares of the MCRB stock.
Still, SEC filings show that on May 15 ’24, von Moltke Lisa disposed off 939 shares at an average price of $0.94 for $883.0. The insider now directly holds 19,017 shares of Seres Therapeutics Inc (MCRB).
